- Product NDC
- 43742-2142
- 11-digit product format
- 437422142
- Labeler code
- 43742
- Product ID
- 43742-2142_1048b4f7-bc6b-42da-8c6e-ae5e11f3299e
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Argentum Nitricum, Aspergillus Niger, Candida Albicans, Euphorbium Officinarum, Gallicum Acidum, Hepar Sulphuris Calcareum, Influenzinum (2023-2024), Luffa Operculata, Mercurius Iodatus Ruber, Mucor Racemosus, Mutabile Bacillus (Bach), Pulsatilla (Pratensis), Sinusitisinum
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- Deseret Biologicals, Inc.
- Marketing category
- UNAPPROVED HOMEOPATHIC
- Marketing start
- 2024-03-13
- Marketing end
- 2029-05-17
- Substance
- ASPERGILLUS NIGER VAR. NIGER; CALCIUM SULFIDE; CANDIDA ALBICANS; ESCHERICHIA COLI; EUPHORBIA RESINIFERA RESIN; GALLIC ACID MONOHYDRATE; INFLUENZA A VIRUS A/DARWIN/6/2021 (H3N2) WHOLE; INFLUENZA A VIRUS WHOLE; INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 WHOLE; INFLUENZA B VIRUS B/PHUKET/3073/2013 BVR-1B WHOLE; LUFFA OPERCULATA FRUIT; MERCURIC IODIDE; MUCOR RACEMOSUS; PULSATILLA PRATENSIS WHOLE; SILVER NITRATE; SINUSITISINUM
- Active strength
- 10; 10; 10; 30; 6; 10; 12; 12; 12; 12; 6; 8; 10; 4; 10; 17 [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
- Pharmacologic classes
- Allergens [CS], Allergens [CS], Allergens [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Fungal Proteins [CS], Fungal Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC]
- NDC exclude flag
- No
- Current FDA listing
- Yes